Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas

Neuropathology and Applied Neurobiology

Volumn 26, Issue 4, 2000, Pages 361-367

  Gutmann, D H ^a   Donahoe, J ^a   Brown, T ^a   James, C D ^a   Perry, A ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Glioma; Neurofibromatosis; Neurofibromin; Pilocytic astrocytoma; Ras

Indexed keywords

NEUROFIBROMIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; ASTROCYTOMA; CHILD; CLINICAL ARTICLE; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NEUROFIBROMATOSIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA, NEOPLASM; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; NERVE TISSUE PROTEINS; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1;

EID: 0033864837     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2000.00258.x     Document Type: Article

References (36)

1. 1 Ballester R, Marchuk DA, Boguski M et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990; 63: 851-9
2. 2 Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J. Aberrant regulation of ras proteins in tumour cells from type 1 neurofibromatosis patients. Nature 1992; 356: 713-5
3. 3 Bollag G, Clapp DW, Shih S et al. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nature Genet 1996; 12: 144-8
4. 4 Borit A, Richardson EPJ. The biological and clinical behavior of pilocytic astrocytomas of the optic pathways. Brain 1982; 105: 161-87
5. 5 Cawthon RM, Weiss M, Xu G et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990; 62: 193-201
6. 6 Colman SD, Williams CA, Wallace MR. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nature Genet 1995; 11: 90-2
7. ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 1992; 69: 265-73
8. 8 Feldkamp MM, Lau N, Provias JP, Gutmann DH, Guha A. Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1: a pathological and molecular explanation. J Neurosurg 1996; 84: 867-73
9. 9 Friedman JM, Gutmann DH, MacCollin M, Riccardi VM. Neurofibromatosis: Phenotype, Natural History and Pathogenesis (3rd edn) Baltimore: Johns Hopkins Press, 1999
10. 10 Giordano MJ, Mahadeo DK, He YY, Geist RT, Hsu C, Gutmann DH. Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemia. J Neuroscience Res 1996; 43: 246-53
11. 11 Gutmann DH, Aylsworth A, Carey JC et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997; 278: 51-7
12. 12 Gutmann DH, Cole JL, Stone WJ, Ponder BAJ, Collins FS. Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type 1. Genes Chromosomes Cancer 1993; 10: 55-8
13. 13 Gutmann DH, Giordano MJ, Mahadeo DK, Lau N, Silbergeld D, Guha A. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras. Oncogene 1996; 12: 2121-7
14. 14 Gutmann DH, Giordano MJ, Fishback AS, Guha A. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 1997; 48: 267-70
15. 15 Gutmann DH, Loehr A, Zhang Y, Kim J, Henkemeyer M, Cashen A. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 1999; 18: 4450-9
16. 16 Gutmann DH, Zhang Y, Hirbe A. Developmental regulation of a neuron-specific neurofibromatosis 1 isoform. Ann Neurol 1999; 46: 777-82
17. 17 Hewett SJ, Choi DW, Gutmann DH. Increased expression of the neurofibromatosis 1 (NF1) tumor suppressor gene protein, neurofibromin, in reactive astrocytes in vitro. Neuroreport 1995; 6: 1505-8
18. 18 Ilgren EB, Kinnier-Wilson LM, Stiller CA. Gliomas in neurofibromatosis: a series of 89 cases with evidence for enhanced malignancy in associated cerebellar astrocytomas. Pathol Annual 1985; 20: 331-58
19. 19 Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System Berlin: Springer - Verlag., 1998: 28-31
20. 20 Knudson AG. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820-3
21. 21 Legius E, Marchuk DA, Collins FS, Glover TW. Somatic deletion of neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumor suppressor gene hypothesis. Nature Genet 1993; 3: 122-6
22. 22 Listernick R, Charrow J, Greenwald MJ, Esterly NB. Optic gliomas in children with neurofibromatosis type 1. J Pediatr 1989; 114: 788-92
23. 23 Listernick R, Charrow J, Greenwald MJ, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatrics 1994; 125: 63-6
24. 24 Listernick R, Louis DN, Packer PJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 optic pathway glioma task force. Ann Neurol 1997; 41: 143-9
25. 25 Martin GA, Viskochil D, Bollag G et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990; 63: 843-9
26. 26 Menon AG, Anderson KM, Riccardi VM et al. Chromosome 17p deletions and p53 gene mutation associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 1990; 87: 5435-9
27. 27 Perilongo G, Moras P, Carollo C et al. Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility. J Child Neurol 1999; 14: 352-6
28. 28 Platten M, Giordano MJ, Dirven CMF, Gutmann DH, Louis DN. Up-regulation of specific NF1 gene transcripts in sporadic pilocytic astrocytomas. Am J Pathol 1996; 149: 621-7
29. 29 Sawada S, Florell S, Purandare SM, Ota M, Stephens K, Viskochil D. Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nature Genet 1996; 14: 110-2
30. 30 Side L, Taylor B, Cayouette M et al. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. New Engl J Med 1997; 336: 1713-20
31. 31 Side LE, Emanuel PD, Taylor B et al. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis type 1. Blood 1998; 92: 267-72
32. 32 von Deimling A, Louis DN, Menon AG, Ellison D, Wiestler OD, Seizinger BR. Deletions on the long arm of chromosome 17 in pilocytic astrocytoma. Arch Neuropathol 1993; 86: 81-5
33. 33 Wallace MR, Marchuk DA, Andersen LB et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990; 249: 181-6
34. 34 Xu G, Lin B, Tanaka K et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 1990; 63: 835-41
35. 35 Xu G, O'Connell P, Viskochil D et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990; 62: 599-608
36. 36 Xu W, Mulligan LM, Ponder MA et al. Loss of NF1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosis. Genes Chromosomes Cancer 1992; 4: 337-42